These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 33918094)
1. Increased Alveolar Heparan Sulphate and Reduced Pulmonary Surfactant Amount and Function in the Mucopolysaccharidosis IIIA Mouse. Paget TL; Parkinson-Lawrence EJ; Trim PJ; Autilio C; Panchal MH; Koster G; Echaide M; Snel MF; Postle AD; Morrison JL; Pérez-Gil J; Orgeig S Cells; 2021 Apr; 10(4):. PubMed ID: 33918094 [TBL] [Abstract][Full Text] [Related]
2. Mucopolysaccharidosis (MPS IIIA) mice have increased lung compliance and airway resistance, decreased diaphragm strength, and no change in alveolar structure. Paget TL; Larcombe AN; Pinniger GJ; Tsioutsias I; Schneider JP; Parkinson-Lawrence EJ; Orgeig S Am J Physiol Lung Cell Mol Physiol; 2024 Jun; 326(6):L713-L726. PubMed ID: 38469649 [TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of brain pathology in heparan sulphate storing mucopolysaccharidoses. Derrick-Roberts A; Kaidonis X; Jackson MR; Liaw WC; Ding X; Ong C; Ranieri E; Sharp P; Fletcher J; Byers S Mol Genet Metab; 2020; 131(1-2):197-205. PubMed ID: 32739280 [TBL] [Abstract][Full Text] [Related]
4. Low-dose, continuous enzyme replacement therapy ameliorates brain pathology in the neurodegenerative lysosomal disorder mucopolysaccharidosis type IIIA. King B; Hassiotis S; Rozaklis T; Beard H; Trim PJ; Snel MF; Hopwood JJ; Hemsley KM J Neurochem; 2016 May; 137(3):409-22. PubMed ID: 26762778 [TBL] [Abstract][Full Text] [Related]
5. Synthetic Disaccharide Standards Enable Quantitative Analysis of Stored Heparan Sulfate in MPS IIIA Murine Brain Regions. He QQ; Trim PJ; Lau AA; King BM; Hopwood JJ; Hemsley KM; Snel MF; Ferro V ACS Chem Neurosci; 2019 Aug; 10(8):3847-3858. PubMed ID: 31264853 [TBL] [Abstract][Full Text] [Related]
6. Abnormal gangliosides are localized in lipid rafts in Sanfilippo (MPS3a) mouse brain. Dawson G; Fuller M; Helmsley KM; Hopwood JJ Neurochem Res; 2012 Jun; 37(6):1372-80. PubMed ID: 22484966 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice. Langford-Smith K; Arasaradnam M; Wraith JE; Wynn R; Bigger BW Mol Genet Metab; 2010 Mar; 99(3):269-74. PubMed ID: 19926322 [TBL] [Abstract][Full Text] [Related]
8. Neurodevelopmental Changes in Excitatory Synaptic Structure and Function in the Cerebral Cortex of Sanfilippo Syndrome IIIA Mice. Dwyer CA; Scudder SL; Lin Y; Dozier LE; Phan D; Allen NJ; Patrick GN; Esko JD Sci Rep; 2017 Apr; 7():46576. PubMed ID: 28418018 [TBL] [Abstract][Full Text] [Related]
9. A simple method for early age phenotype confirmation using toe tissue from a mouse model of MPS IIIA. Trim PJ; Lau AA; Hopwood JJ; Snel MF Rapid Commun Mass Spectrom; 2014 Apr; 28(8):933-8. PubMed ID: 24623698 [TBL] [Abstract][Full Text] [Related]
10. Exocytosis is impaired in mucopolysaccharidosis IIIA mouse chromaffin cells. Keating DJ; Winter MA; Hemsley KM; Mackenzie KD; Teo EH; Hopwood JJ; Brooks DA; Parkinson-Lawrence EJ Neuroscience; 2012 Dec; 227():110-8. PubMed ID: 23022219 [TBL] [Abstract][Full Text] [Related]
11. Neuronal-specific impairment of heparan sulfate degradation in Drosophila reveals pathogenic mechanisms for Mucopolysaccharidosis type IIIA. Webber DL; Choo A; Hewson LJ; Trim PJ; Snel MF; Hopwood JJ; Richards RI; Hemsley KM; O'Keefe LV Exp Neurol; 2018 May; 303():38-47. PubMed ID: 29408731 [TBL] [Abstract][Full Text] [Related]
12. Systemic scAAV9.U1a.hSGSH Delivery Corrects Brain Biochemistry in Mucopolysaccharidosis Type IIIA at Early and Later Stages of Disease. Saville JT; Derrick-Roberts ALK; McIntyre C; Fuller M Hum Gene Ther; 2021 Apr; 32(7-8):420-430. PubMed ID: 33339477 [TBL] [Abstract][Full Text] [Related]
13. Robust LC-MS/MS methods for analysis of heparan sulfate levels in CSF and brain for application in studies of MPS IIIA. Makower Å; Arnelöf E; Andersson T; Edlund PO; Gustavsson S; Janson J; Gelius SS; Tjernberg A Bioanalysis; 2019 Aug; 11(15):1389-1403. PubMed ID: 31490106 [No Abstract] [Full Text] [Related]
14. Multivalent, calcium-independent binding of surfactant protein A and D to sulfated glycosaminoglycans of the alveolar epithelial glycocalyx. Avcibas R; Vermul A; Gluhovic V; Boback N; Arroyo R; Kingma P; Isasi-Campillo M; Garcia-Ortega L; Griese M; Kuebler WM; Ochs M; Lauster D; Lopez-Rodriguez E Am J Physiol Lung Cell Mol Physiol; 2024 May; 326(5):L524-L538. PubMed ID: 38375572 [TBL] [Abstract][Full Text] [Related]
15. Lung surfactant in a cystic fibrosis animal model: increased alveolar phospholipid pool size without altered composition and surface tension function in cftrm1HGU/m1HGU mice. Bernhard W; Wang JY; Tschernig T; Tümmler B; Hedrich HJ; von der Hardt H Thorax; 1997 Aug; 52(8):723-30. PubMed ID: 9337833 [TBL] [Abstract][Full Text] [Related]
16. Slow, continuous enzyme replacement via spinal CSF in dogs with the paediatric-onset neurodegenerative disease, MPS IIIA. King B; Marshall NR; Hassiotis S; Trim PJ; Tucker J; Hattersley K; Snel MF; Jolly RD; Hopwood JJ; Hemsley KM J Inherit Metab Dis; 2017 May; 40(3):443-453. PubMed ID: 27832416 [TBL] [Abstract][Full Text] [Related]